Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 95 (RPL21P95)

Target: RPL21P95
Molecular classification: Other (pseudogene, not a protein-coding gene)

Overview

Ribosomal protein L21 pseudogene 95 (RPL21P95) is a processed pseudogene in the human genome, derived from the parent ribosomal protein L21 gene. Pseudogenes like RPL21P95 do not encode functional proteins, and are typically considered non-functional remnants of gene duplication or retrotransposition events. This locus does not produce ribosomal proteins nor does it have any established biological, disease, or therapeutic relevance[3][11].

Other names: RPL21_40_1159RPL21P95

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 95 (RPL21P95).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 95 (RPL21P95).

Explore the full profile